Engineering Synthetic Erythrocytes as Next‐Generation Blood Substitutes
Advanced Functional Materials · 2024-07 · 34 (28)
DOI: 10.1002/adfm.202315879 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 08.02.2024. Verfasst von Francisca L Gomes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecules and Materials, Laboratory of Biointerface Chemistry, Faculty of Science and Technology, Technical Medical Centre and MESA+ In…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, Health~Holland, National Institutes of Health.
Abstract (Originalsprache)
Blood scarcity is one of the main causes of healthcare disruptions worldwide, with blood shortages occurring at an alarming rate. Over the last decades, blood substitutes have aimed at reinforcing the supply of blood, with several products (e.g., hemoglobin (Hb)‐based oxygen (O 2 ) carriers, perfluorocarbons (PFC)) achieving a limited degree of success. Regardless, there is still no widespread solution to this problem due to persistent challenges in product safety and scalability. In this Review, different advances are described in the field of blood substitution, particularly in the development of artificial red blood cells, otherwise known as engineered erythrocytes (EE). The different strategies are categorized into natural, synthetic, or hybrid approaches, and discuss their potential in terms of safety and scalability. Synthetic EEs are identified as the most powerful approach, and describe erythrocytes from a materials engineering perspective. Their biological structure and function are reviewed, as well as explore different methods of assembling a material‐based cell. Specifically, it is discussed how to recreate size, shape, and deformability through particle fabrication, and how to recreate the functional machinery through synthetic biology and nanotechnology. It is concluded by describing the versatile nature of synthetic erythrocytes in medicine and pharmaceuticals and propose specific directions for the field of erythrocyte engineering.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecules and Materials, Laboratory of Biointerface Chemistry, Faculty of Science and Technology, Technical Medical Centre and MESA+ Institute, University of Twente, Drienerlolaan 5, Enschede, 7522NB,The N…
- Department of Developmental BioEngineering, Leijten Laboratory, Faculty of Science and Technology, Technical Medical Centre, University of Twente, Drienerlolaan 5, Enschede, 7522NB, The Netherlands.
- Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 65 Landsdowne Street, Cambridge, MA, 02139, USA.
Förderung
- NIAMS NIH HHS
- Health~Holland
- National Institutes of Health
Zitieren
APA
Gomes, F. L., Jeong, S. H., Shin, S. R., Leijten, J., & Jonkheijm, P. (2024). Engineering Synthetic Erythrocytes as Next‐Generation Blood Substitutes. Advanced Functional Materials, 34(28). https://doi.org/10.1002/adfm.202315879
Vancouver
Gomes FL, Jeong SH, Shin SR, Leijten J, Jonkheijm P. Engineering Synthetic Erythrocytes as Next‐Generation Blood Substitutes. Advanced Functional Materials. 2024;34(28). doi:10.1002/adfm.202315879
BibTeX
@article{Gomes2024,
author = {Gomes, Francisca L and Jeong, Seol-Ha and Shin, Su Ryon and Leijten, Jeroen and Jonkheijm, Pascal},
title = {Engineering Synthetic Erythrocytes as Next‐Generation Blood Substitutes},
journal = {Advanced Functional Materials},
year = {2024},
volume = {34},
number = {28},
doi = {10.1002/adfm.202315879}
}
EUVIMED